Taking Open Innovation to the Molecular Level - Strengths and Limitations
- Author(s)
- Barbara Zdrazil, Niklas Blomberg, Gerhard Ecker
- Abstract
The ever-growing availability of large-scale open data and its maturation is having a significant impact on industrial drug-discovery, as well as on academic and non-profit research. As industry is changing to an open innovation business concept, precompetitive initiatives and strong public-private partnerships including academic research cooperation partners are gaining more and more importance. Now, the bioinformatics and cheminformatics communities are seeking for web tools which allow the integration of this large volume of life science datasets available in the public domain. Such a data exploitation tool would ideally be able to answer complex biological questions by formulating only one search query. In this short review/perspective, we outline the use of semantic web approaches for data and knowledge integration. Further, we discuss strengths and current limitations of public available data retrieval tools and integrated platforms.
- Organisation(s)
- External organisation(s)
- AstraZeneca
- Journal
- Molecular Informatics
- Volume
- 31
- Pages
- 528-535
- No. of pages
- 8
- ISSN
- 1868-1743
- DOI
- https://doi.org/10.1002/minf.201200014
- Publication date
- 08-2012
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry, 301305 Medical chemistry
- Sustainable Development Goals
- SDG 9 - Industry, Innovation, and Infrastructure
- Portal url
- https://ucris.univie.ac.at/portal/en/publications/taking-open-innovation-to-the-molecular-level--strengths-and-limitations(754d694f-bd0f-4e24-81a0-579dc8ce4d91).html